Overcoming resistance to EGFR monotherapy in HNSCC by identification and inhibition of individualized cancer processes
Sign Up to like & getrecommendations! Published in 2022 at "Theranostics"
DOI: 10.7150/thno.64347
Abstract: Therapeutic strategies for advanced head and neck squamous carcinoma (HNSCC) consist of multimodal treatment, including Epidermal Growth Factor Receptor (EGFR) inhibition, immune-checkpoint inhibition, and radio (chemo) therapy. Although over 90% of HNSCC tumors overexpress EGFR,… read more here.
Keywords: inhibition; egfr monotherapy; hnscc tumors; hnscc ... See more keywords